Our results confirm the relationship between circulating levels of IL-6 and fatigue intensity in prostate cancer patients undergoing curative radiotherapy and may contribute to further understanding of biological factors underlying fatigue. This evidence concerns the gene IL6 and Familial prostate cancer.